Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex®/ Daivobet®/Dovobet® ointment): Hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris

Journal of Drugs in Dermatology

Volumn 9, Issue 8, 2010, Pages 969-974

  Fleming, Colin ^a   Ganslandt, Cecilia ^b   Leese, Graham P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; BETAMETHASONE; BETAMETHASONE DIPROPIONATE, CALCIPOTRIOL DRUG COMBINATION; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE;

ADRENAL SUPPRESSION; ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM CARE; MALE; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SIDE EFFECT; TREATMENT DURATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; OINTMENT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSORIASIS; TIME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; OINTMENTS; PITUITARY-ADRENAL SYSTEM; PROSPECTIVE STUDIES; PSORIASIS; TIME FACTORS; YOUNG ADULT;

EID: 77955875744     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kaufmann R, Bibby AJ, Bissonnette R, et al. A new calcipotriol/ betamethasone dipropionate formulation (Daivobet™) is an effective once-daily treatment for psoriasis vulgaris. Dermatology. 2002;205:389-393. (Pubitemid 35356768)
2. Kragballe K, Nørrelund KL, Lui H, et al. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol. 2004;150:1167-1173. (Pubitemid 38932288)
3. Ortonne JP, Kaufmann R, Lecha M, Goodfield M. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: A randomised, double-blind trial. Dermatology. 2004;209:308-313. (Pubitemid 39482622)
4. Papp K A, Guenther L, Boyden B, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol. 2003;48:48-54. (Pubitemid 36091533)
5. Douglas WS, Poulin Y, Decroix J, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol. 2002;82:131-135. (Pubitemid 34596689)
6. Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency. Am J Dermatol. 2002;3(3):141-147.
7. Weston WL, Fennessey PV, Morelli J, et al. Comparison of hypothalamus- pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol. 1988;90(4):532-535. (Pubitemid 18094886)
8. Hengge UR, Ruzicka T, Schwartz A, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15.
9. Kragballe K, Austad J, Barnes L, et al. A 52-week randomised safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris. Br J Dermatol. 2006;154:1155-1160. (Pubitemid 43727399)
10. Kragballe K, Austad J, Barnes L, et al. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet®/ Dovobet®/ Taclonex®) in the treatment of psoriasis vulgaris. Br J Dermatol. 2006;213:319-326. (Pubitemid 44837020)